You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Galapagos signs deal with Scipher for IBD drug development

Belgium-based biotech Galapagos has signed a collaboration deal with Scipher Medicine to advance novel drug targets for the treatment of inflammatory bowel disease (IBD).